Actuate Therapeutics, Inc. (ACTU) Q1 2025 Earnings
ACTU·Reported May 15, 2025·Before market open
Diluted EPS came in at $-0.32, missed the $-0.30 consensus by $0.02.
Diluted EPS
$-0.32missed by $0.02
Consensus: $-0.30
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Actuate Therapeutics, Inc.'s Q1 2025 earnings report.
Actuate Therapeutics, Inc. (ACTU) reported Q1 2025 earnings on May 15, 2025 before market open.
Actuate Therapeutics, Inc. reported diluted EPS of $-0.32 for Q1 2025.
EPS missed the consensus estimate of $-0.30 by $0.02.
You can read the 10-Q periodic report (0001683168-25-003705) directly on SEC EDGAR. The filing index links above go to sec.gov.